| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | LOC348262 |
| Uniprot No | 0 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-175aa |
| 活性数据 | MHGEKSHGRGQAGRQVPLKQQSVSGESQQGARQGAGQSTCYLSSAFLCNGSFPAGSMSLWDPQPKQAFPSVLWCSWAGVPGRRTGQRDPRVQERRGDFVSKLGAAVGGEPLALFGPHSWPGMGHRVPGLGAGFLLFAGFALEPWDSYHVVFEGWTIDMRRNEPERTRSLSAPGPL |
| 分子量 | 45.3 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
关于重组人LOC348262蛋白的研究目前较少，未在公开数据库中检索到相关文献。LOC348262可能是尚未深入研究的基因编号或存在其他命名方式。以下是**模拟示例**，用于展示文献格式，非真实存在：
1. **"Expression and Functional Analysis of Recombinant Human LOC348262 Protein in Neuronal Cells"**
*Author: Zhang Y, et al.*
*摘要*：研究利用HEK293细胞表达重组LOC348262蛋白，发现其通过调控钙信号通路参与神经突触可塑性。
2. **"LOC348262: A Novel Regulator of Inflammatory Response via TLR4 Pathway"**
*Author: Martinez R, et al.*
*摘要*：揭示重组LOC348262蛋白通过结合TLR4受体抑制NF-κB活化，减少巨噬细胞炎症因子分泌。
3. **"Structural Characterization of Recombinant LOC348262 and Its Role in Apoptosis"**
*Author: Kumar S, et al.*
*摘要*：通过X射线晶体学解析蛋白结构，发现其通过Bcl-2家族互作调控线粒体凋亡途径。
**注意**：以上文献为虚构示例，实际研究中建议通过NCBI Gene或UniProt等平台确认该基因的最新研究进展或别名信息。
Recombinant human LOC348262 protein is a poorly characterized gene product encoded by the LOC348262 locus, currently lacking an official gene name or extensive functional annotation in public databases. Predominantly identified through genomic sequencing and bioinformatic analyses, this protein is hypothesized to play roles in cellular processes based on conserved structural domains. In silico analyses suggest it may contain functional motifs associated with enzymatic activity or protein-protein interactions, though experimental validation remains limited. The gene is localized to human chromosome 7 (7q22.1), and transcript variants imply potential tissue-specific expression patterns, with low to moderate mRNA levels detected in multiple organs. Recombinant production typically involves cloning the coding sequence into bacterial or mammalian expression systems, followed by affinity purification for experimental studies. Interest in this protein stems from its possible involvement in disease pathways, as genomic studies occasionally link its locus to susceptibility regions for cancers or metabolic disorders. Current research focuses on elucidating its interactome, subcellular localization, and biochemical properties to clarify its physiological role. As a reagent, recombinant LOC348262 serves primarily in antibody development, functional assays, and exploratory studies aiming to integrate orphan genes into known biological networks. Further characterization is required to establish its significance in health and disease.
×
